Impact of alpha-lipoic acid on salivary production in patients receiving radiotherapy for head and neck cancer: a randomized clinical study

• by Fahimeh Anbari, Seyedeh Masoumeh Heydari, Sedigheh Bakhtiari, Sepehr Younesi Pour Masouleh, Samira Azghandi, Hoora Bakhtiyari

• January 31, 2026

Perioperative immunotherapy in resectable HNSCC: biological rationale to practical multidisciplinary implementation

• by Michel Bila, Vincent Vander Poorten, Jeroen Meulemans, Wouter Huvenne, Wouter De Vos, Robin Willaert, Joke De Ceulaer, Paul M. Clement

• May 15, 2026

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.

• by Heather Sloan, Sarah J. Jennings, Kristi Adair, Anne Stein

• May 6, 2026

• 24 min

Neoadjuvant Radiotherapy with Camrelizumab as a Chemotherapy-Sparing Strategy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Results from a Phase II Trial (ESOCORT-NIRT)

• by Maohui Chen, Yizhou Huang, Shuliang Zhang, Cheng Chen, Taidui Zeng, Hongmu Li, Zhenyuan Yang, Chuanquan Lin, Wei Li, Benhua Xu, Chun Chen, Bin Zheng

• March 9, 2026